SARS_CoV_2 mutation literature information.


  Role of Q675H Mutation in Improving SARS-CoV-2 Spike Interaction with the Furin Binding Pocket.
 PMID: 34960779       2021       Viruses
Method: Pymol mutagenesis wizard was used to model Q675H and D614G for both wild-type (wt) and mutant systems.
Result: In particular, in B.1.438.1, B.1.438.2, B.1.438.3, and B.1.1.385 lineages, Q675H and D614G are the sole mutations located in the spike protein.


  Prediction of SARS-CoV-2 Variant Lineages Using the S1-Encoding Region Sequence Obtained by PacBio Single-Molecule Real-Time Sequencing.
 PMID: 34960813       2021       Viruses
Introduction: It harbors three aa deletions (69del-70del and 144del) and seven mutations in the spike protein, including D614G and N501Y.
Introduction: One of the first notable variants had a D614G substitution in the S1 domain that increased the affinity of the virus for ACE2.
Result: For example, a variant harboring mutations S477N and D614G was identified as belonging to lineage B.1.160.


  Discovery of potential anti-SARS-CoV-2 drugs based on large-scale screening in vitro and effect evaluation in vivo.
 PMID: 34962614       2021       Science China. Life sciences
Abstract: Seven compounds reduced weight loss and promoted weight regain of hamsters infected not only with the original strain but also the D614G variant.


  A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.
 PMID: 34966387       2021       Frontiers in immunology
Method: The fold change of the mutant spike relative to WT D614G in binding or neutralization was calculated by simple division of the respective IC50 or MFI values.
Figure: (C-E) The relative mean fluorescence intensity (MFI) of mAbs or ACE2 binding was determined by comparing the total MFI in the selected gate between the spike variants and WT D614G.
Figure: The IC50 of antibodies against WT D614G are listed in (A).


  SARS-CoV-2 Variants: Mutations and Effective Changes.
 PMID: 34975266       2021       Biotechnology and bioprocess engineering
Abstract: Certain mutations (D614G, E484K, N501Y, K417N, L452R and P681R) have appeared across several different strains, often accompanied by others that may be complementary working together to confer increased infectivity, fitness, or resistance to neutralization.


  SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster.
 PMID: 34981057       2021       bioRxiv
Abstract: A booster vaccination significantly increased titers against Omicron to levels comparable to those seen against the ancestral (D614G) variant after two immunizations.
Introduction: We compared the magnitude of neutralization escape by Omicron to D614G (referred to as wild type, WT) and Delta SARS-CoV-2 variants to help inform public health decisions and offer further data toward correlate of protection research.
Discussion: Here, using the same lentiviral pseudovirus neutralization platform we measured the change in potency of 24 clinical-stage therapeutic antibodies against Omicron compared to WT (D614G) and compared neutralizing antibodies in sera from two well-characterized cohorts of subjects in prospective clinical studies.


  Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody Treatment.
 PMID: 32357545       2020       Pathogens (Basel, Switzerland)
Conclusion: The highly prevalent 23403A>G (p.D614G) variant in the European population ma
Discussion: A recent report corroborated our findings of high prevalence of D614G in Europe.
Discussion: However, given the small sample size, it is hard to ascertain whether D614G is the dominant strain in these countries.


  A Novel Synonymous Mutation of SARS-CoV-2: Is This Possible to Affect Their Antigenicity and Immunogenicity?
 PMID: 32422894       2020       Vaccines
Abstract: These two subtypes were divided by a novel synonymous mutation of D614G.
Introduction: If the mutation of D614G plays a crucial role in the positive selection process, SARS-CoV-2b will be the dominant type of SARS-CoV-2 in the future.
Introduction: Since no amino acid changes were found in this area other than the change of D614G, it is believed that this amino acid change alters the conformation of these immunogenic determinants; consequently, this region is expected to no longer act as a B-cell epitope in SARS-CoV-2b.


  Molecular Detection of SARS-CoV-2 Infection in FFPE Samples and Histopathologic Findings in Fatal SARS-CoV-2 Cases.
 PMID: 32451533       2020       American journal of clinical pathology
Table: D614G


  Could the D614G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality?
 PMID: 32464271       2020       International journal of infectious diseases
Introduction: For example, a substantial number of strains with the S-D614G variant are from the countries Belgium, Spain, Italy, France, Netherlands, and Switzerland that top the death toll (Figure 1B) (https://www.worldometers.info/coronavirus/; last accessed May 2, 2020); while Germany and Kuwait, with a lower death toll, constitute most strains with the wild-type 614D at S (Figure 1B).
Introduction: Overall, our observation speculates that the S-D614G strains may be more
Figure: The mutation observed at the S protein of the SARS-COV-2, D614G in white color, may create conformational changes mimicking the open status and facilitate the cleavage domain's exposure to proteases FURIN or TMPRSS2 and could be sufficient to speed up the cleavage.



Browser Board

 Co-occurred Entities




   Filtrator